XML 28 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 43,619 $ 30,607
Adjustments to reconcile net income to net cash provided by operating activities:    
Net accretion of acquisition accounting estimates (9,549) (11,528)
Provision for credit losses 5,548 3,958
Depreciation and amortization 11,741 12,040
Net amortization of securities 92 (622)
Amortization of debt issuance costs 82 91
Gain on mortgage loans held for sale (4,586) (2,331)
Gain on other mortgage loan activity (36) (566)
Proceeds from sale of mortgage loans held for sale 145,714 117,230
Originations of loans held for sale (143,697) (131,851)
Stock-based compensation expense 1,357 1,252
Deferred income tax expense 482 7,776
Loss on sales of repossessed assets 164 375
Loss (gain) on valuation adjustments on mortgage servicing rights 691 (253)
Loss on disposal of fixed assets 147 10
Loss on disposal of premises held for sale 61 0
Valuation adjustments on premises transferred to held for sale 0 2
Loss on sales and valuation adjustments on other real estate owned 59 0
Fair value adjustment on equity securities (163) (124)
Bank owned life insurance income (2,127) (2,037)
Net changes in:    
Accrued interest receivable (838) (775)
Other assets (4,114) (3,267)
Accrued interest payable 5 (1,084)
Other liabilities 9,261 (4,435)
Net cash provided by operating activities 53,913 14,468
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from maturities and principal payments of available for sale securities 19,840 64,896
Proceeds from maturities and principal payments of held to maturity securities 49,661 39,653
Proceeds from life insurance death benefits 1,714 150
Purchases of available for sale securities (48,198) (83,990)
Purchases of held to maturity securities (2,325) (11,449)
Purchases of equity securities (136) (123)
Purchase of restricted securities (111) (35,682)
Net change in loans (104,368) (84,580)
Purchases of premises and equipment (2,491) (3,969)
Proceeds from sales of repossessed assets 1,852 1,807
Redemption of restricted securities 0 33,329
Purchases of bank owned life insurance (221) (138)
Proceeds from disposal of premises held for sale 843 0
Net cash used in investing activities (83,940) (80,096)
Net changes in:    
Noninterest-bearing deposits 31,397 313,356
Interest-bearing deposits (32,616) (474,828)
Long-term borrowings 0 50,000
Common stock dividends paid (12,092) (12,013)
Issuance of common stock 0 321
Net cash used in financing activities (13,311) (123,164)
Net decrease in cash and cash equivalents (43,338) (188,792)
Cash and cash equivalents at beginning of period 459,851 372,413
Cash and cash equivalents at end of period 416,513 183,621
Supplemental cash flows information:    
Interest paid 86,106 91,619
Income taxes paid 12,205 0
Recognition of lease liabilities arising from right-of-use assets 1,166 25
Transfers from loans to repossessed assets 2,300 2,488
Transfer from loans held for sale to loans held for investment 649 0
Unrealized gains on available for sale securities 3,834 2,708
Transfer of premises to held for sale, included in other assets $ 0 $ 1,387